Search results for "ddc:615"

showing 8 items of 8 documents

Comparing metoclopramide electrotransport kinetics in vitro and in vivo.

2010

The purpose of this work was to investigate the transdermal iontophoretic delivery of metoclopramide and to determine (i) the dependence of electrotransport on current density and drug concentration, (ii) the relative contributions of electromigration and electroosmosis and (iii) the feasibility of administering therapeutic amounts of drug, using a drug-sparing iontophoretic configuration. Iontophoretic delivery of metoclopramide (MCL) across dermatomed porcine ear skin was investigated in vitro as a function of concentration (10, 20, 40, 80 and 100mM) and current density (0.1, 0.2 and 0.3mAcm(-2)) using vertical flow-through diffusion cells. In vivo studies were performed in Wistar rats (4…

DrugMaleMetoclopramideMetoclopramideSwinemedia_common.quotation_subjectPharmaceutical SciencePharmacologyPharmaceutical formulationIn Vitro TechniquesPharmacokineticsIn vivomedicineAnimalsRats WistarAntiemetics/pharmacokineticsMetoclopramide/pharmacokineticsmedia_commonTransdermalddc:615IontophoresisChemistryIn vitroRatsAntiemeticsmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Transdermal therapy and diagnosis by iontophoresis

1997

Iontophoresis, the use of an electric current to drive charged molecules across the skin, has the potential to expand the feasible range of drugs for transdermal administration significantly. This method of delivery is being examined carefully with respect to higher-molecular-weight therapeutics (in particular, peptides and small proteins), which cannot be absorbed following oral administration and for which, at this time, an invasive injection remains the only option. In addition, the procedure of so-called 'reverse' iontophoresis would appear to represent a truly noninvasive approach for diagnostic monitoring of blood chemistry.

Drugddc:615Skin Diseases/diagnosis/therapyPeptides/administration & dosageIontophoresisbusiness.industrymedia_common.quotation_subjectBiotechnology/trendsBioengineeringIontophoresis/methodsIontophoresisPharmacologyAdministration CutaneousDiagnostic monitoringSkin DiseasesBlood chemistryOral administrationHumansMedicinePeptidesbusinessBiotechnologymedia_commonTransdermalTrends in Biotechnology
researchProduct

Controlled Iontophoretic Delivery in Vitro and in Vivo of ARN14140—A Multitarget Compound for Alzheimer’s Disease

2019

ARN14140 is a galantamine-memantine conjugate that acts upon both cholinergic and glutamatergic pathways for better management of Alzheimer's disease. Poor oral bioavailability and pharmacokinetics meant that earlier preclinical in vivo studies employed intracerebroventricular injection to administer ARN14140 directly to the brain. The aim of the present study was to evaluate the feasibility of using constant current transdermal iontophoresis for the noninvasive systemic delivery of ARN14140 and to quantify the amounts present in the blood and the brain. Preliminary experiments in vitro were performed using porcine skin and validated with human skin. Cumulative ARN14140 permeation across th…

MaleSwineSkin Absorptionbrain deliveryBiological AvailabilityPharmaceutical ScienceHuman skin02 engineering and technologyPharmacologyAdministration Cutaneous030226 pharmacology & pharmacyPermeability03 medical and health sciences0302 clinical medicineDrug StabilityPharmacokineticsIn vivoDrug DiscoveryARN14140AnimalsBrain/metabolismHumansSkin/metabolismMedicineTissue DistributionRats WistarNootropic Agents/administration & dosage/pharmacokineticsTransdermalddc:615galantamine-memantine conjugateAlzheimer Disease/drug therapyIontophoresisbusiness.industryGalantamine/administration & dosage/pharmacokineticsiontophoresiIontophoresisMemantine/administration & dosage/pharmacokinetics021001 nanoscience & nanotechnologyIn vitroRatsBioavailabilityHeterocyclic Compounds 4 or More Rings/administration & dosage/pharmacologytransdermalFeasibility StudiesMolecular MedicineCholinergic0210 nano-technologybusinessMolecular Pharmaceutics
researchProduct

Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability a…

2010

The aim of this study was to investigate the cathodal iontophoresis of dexamethasone sodium phosphate (DEX-P) in vitro and in vivo and to determine the feasibility of delivering therapeutic amounts of the drug for the treatment of chemotherapy-induced emesis. Stability studies, performed to investigate the susceptibility of the phosphate ester linkage to hydrolysis, confirmed that conversion of DEX-P to dexamethasone (DEX) upon exposure to samples of human, porcine and rat dermis for 7 h was limited (82.2+/-0.4%, 72.5+/-4.8% and 78.6+/-6.0% remained intact) and did not point to any major inter-species differences. Iontophoretic transport of DEX-P across dermatomed porcine skin (0.75 mm thic…

MaleTime FactorsVomitingSwineSkin AbsorptionPharmaceutical ScienceAntineoplastic AgentsPharmacologyAdministration CutaneousHigh-performance liquid chromatographyDexamethasoneGlucocorticoids/administration & dosage/pharmacokineticsDexamethasone Sodium PhosphatePharmacokineticsDrug StabilitySpecies SpecificityIn vivoAnimalsHumansSkin/metabolismVomiting/chemically induced/prevention & controlRats WistarGlucocorticoidsTransdermalSkinddc:615IontophoresisDose-Response Relationship DrugChemistryHydrolysisGeneral MedicineAntineoplastic Agents/adverse effectsPermeationIontophoresisRatsDose–response relationshipDexamethasone/administration & dosage/analogs & derivatives/pharmacokineticsBiotechnologyNuclear chemistry
researchProduct

Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison…

2010

The objectives of the study were (i) to investigate the effect of experimental parameters on the iontophoretic transport of granisetron, (ii) to identify the relative contributions of electromigration (EM) and electroosmosis (EO), (iii) to determine the feasibility of delivering therapeutic amounts of drug for the treatment of chemotherapy-induced nausea and vomiting and (iv) to test the in vitro results in a simple animal model in vivo. Preliminary in vitro studies using aqueous granisetron formulations investigating the effect of drug concentration (5, 10, 20 and 40 mM) and current density (0.1, 0.2, 0.3 mA cm(-2)) were performed using porcine ear skin. As expected, cumulative delivery in…

Malemedicine.drug_classSwinePharmaceutical ScienceIontophoresis/methodsPharmacologyIn Vitro TechniquesGranisetronAdministration CutaneousHigh-performance liquid chromatographyGranisetronPharmacokineticsIn vivoLimit of DetectionGranisetron/administration & dosage/pharmacokineticsSkin/metabolismMedicineAntiemeticAnimalsRats WistarChromatography High Pressure LiquidTransdermalSkinddc:615Iontophoresisbusiness.industryHalf-lifeIontophoresisAntiemetics/administration & dosage/pharmacokineticsRatsSerotonin Antagonists/administration & dosage/pharmacokineticsArea Under CurveAntiemeticsSerotonin Antagonistsbusinessmedicine.drugHalf-LifeEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Ultra-short ion-exchange columns for fast charge variants analysis of therapeutic proteins

2021

Abstract The purpose of this work was to study the potential of recently developed ultra-short column hardware for ion exchange chromatography (IEX). Various prototype and commercial columns having lengths of 5, 10, 15, 20 and 50 mm and packed with non-porous 3 µm particles were systematically compared. Both pH and salt gradient modes of elution were evaluated. Similarly, what has been previously reported for reversed phase liquid chromatography (RPLC) mode, an “on-off” retention mechanism was observed in IEX for therapeutic proteins and their fragments (25–150 kDa range). Because of the non-porous nature of the IEX packing material, the column porosity was relatively low (e = 0.42) and the…

Monoclonal antibodyChromatography Reverse-PhaseRange (particle radiation)ddc:615ChromatographyIon exchangeChemistryElutionOrganic ChemistryIon chromatographyIon-exchange chromatographyGeneral MedicineReversed-phase chromatographyChromatography Ion ExchangeBiochemistryUltra-short columnExtra-column volumeAnalytical ChemistryVolume (thermodynamics)PeekPorosityFast separationPorosityChromatography High Pressure Liquid
researchProduct

Transdermal and Skin-Targeted Drug Delivery

1997

Background: The application of therapeutic agents to the skin addresses three general objectives: (a) the treatment of a variety of dermatologic diseases; (b) the “targeted” delivery of drugs to deeper subcutaneous tissues, with a concomitant reduction in systemic exposure; and (c) socalled transdermal administration to elicit a systemic pharmacologic effect. Objective: Recently, significant progress towards all three goals has been recorded and the level of research and development activity remains high. We aim to discuss these advances from mechanistic and clinical standpoints. Results: For the topical treatment of skin disease, novel vehicles (e.g., stabilized, supersaturated systems and…

SonophoresisDermatologyPharmacology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineSmall peptideTransdermal drug deliveryMedicineChemical penetration enhancersTransdermalddc:615LiposomeIontophoresisbusiness.industryIontophoresisControlled releasePatch technologyBioavailabilityElectroporationTargeted drug delivery030220 oncology & carcinogenesisLiposomesDrug deliverySurgerybusinessJournal of Cutaneous Medicine and Surgery
researchProduct

Iontophoresis: electrorepulsion and electroosmosis.

2000

Over the last 10-15 years, the electrical enhancement of drug delivery across the skin has undergone intense investigation. During this period, considerable amounts of experimental data have been generated, and the successful enhancement of a diverse array of molecules has been achieved. Indeed, the commercial exploitation of the method can be envisaged within the next few years. Despite this progress, however, the mechanistic understanding of iontophoresis remains a challenging scientific question that is yet to be fully resolved. The routes of permeation under the influence of an applied electrical potential, and the molecular interactions of the transporting drug with these pathways, hav…

ddc:615Molecular interactionsOsmosisIontophoresisChemistryPharmaceutical ScienceNanotechnologyIontophoresisAdministration CutaneousDrug Delivery SystemsPharmaceutical technologyElectricitySkin Physiological PhenomenaDrug deliveryDrug Delivery Systems/methodsJournal of controlled release : official journal of the Controlled Release Society
researchProduct